小児神経デバイス市場規模、シェア、成長分析：製品別、サービスと治療別、神経学的専門分野別、年齢層別、エンドユーザー別、用途別、地域別 - 産業予測 2025～2032年

小児神経デバイスの市場規模は2023年に37億米ドルで、2024年の39億6,000万米ドルから2032年には67億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは6.9%で成長する見通しです。

小児神経疾患の世界の急増が、神経学専用機器の需要を大きく牽引しています。小児における低リスクおよび高リスクの神経疾患の診断の増加は、多くの場合、傷害、神経毒への曝露、遺伝的要因に起因しており、差し迫った必要性を浮き彫りにしています。発作は依然としてこの層で最も多く見られる疾患であり、小児医療に合わせた機器の必要性が強調されています。神経学研究への投資の開拓は、先進デバイスの開発における技術革新を促進し、機械学習やAIを含むヘルスケア技術の進歩は、市場のさらなる変革を約束しています。さらに、小児神経疾患に対する認識を高めることを目的とした政府の取り組みが、デバイスの販売を強化し、この分野の成長に向けた強固な状況を作り出すと期待されています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

小児神経デバイス市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 脳神経外科用機器
• 神経刺激装置
• 脳脊髄液（CSF）管理デバイス
• その他

小児神経デバイス市場規模：サービスと治療別& CAGR（2025-2032）

• 市場概要
• 脳波
• 髄腔内バクロフェン療法
• 神経学的評価
• 迷走神経刺激

小児神経デバイス市場規模：神経学専門医分野別& CAGR（2025-2032）

• 市場概要
• 神経腫瘍学
• 神経筋
• 新生児神経学
• 神経免疫学
• 脳卒中

小児神経デバイス市場規模：年齢層別& CAGR（2025-2032）

• 市場概要
• 新生児
• 乳児
• 子供
• 青少年

小児神経デバイス市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• ヘルスケアセンター
• 専門クリニック
• 神経学研究センター

小児神経デバイス市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 脳腫瘍
• てんかん
• 自閉症スペクトラム障害
• パーキンソン病
• その他

小児神経デバイス市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic plc（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Johnson & Johnson（USA）
• LivaNova PLC（UK）
• Integra LifeSciences（USA）
• Natus Medical Incorporated（USA）
• Nihon Kohden Corporation（Japan）
• B. Braun Melsungen AG（Germany）
• Stryker Corporation（USA）
• Siemens Healthineers AG（Germany）
• Philips Healthcare（Netherlands）
• Computational Diagnostics, Inc.（USA）
• Elekta AB（Sweden）
• NeuroPace, Inc.（USA）
• Terumo Corporation（Japan）
• Smith+Nephew（UK）
• Mizuho OSI（USA）
• Orpyx Medical Technologies Inc.（Canada）
• Magstim（UK）

結論と提言

Pediatric Neurology Device Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 3.96 billion in 2024 to USD 6.75 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global surge in pediatric neurological disorders is significantly driving the demand for specialized neurology devices. An increase in diagnoses of both low-risk and high-risk neurological conditions among children-often attributed to injuries, exposure to neurotoxins, and genetic factors-highlights a pressing need. Seizures remain the most prevalent disorder in this demographic, underscoring the necessity for devices tailored for pediatric care. Growing investment in neurological research is fostering innovation in the development of advanced devices, while advancements in healthcare technology, including machine learning and AI, promise to revolutionize the market further. Additionally, government initiatives aimed at raising awareness of pediatric neurological disorders are expected to bolster device sales, creating a robust landscape for growth in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pediatric Neurology Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pediatric Neurology Device Market Segments Analysis

Global Pediatric Neurology Device Market is segmented by Product, Service and Treatment, Neurological Specialty, Age Group, End User, Application and region. Based on Product, the market is segmented into Neurosurgery Devices, Neurostimulator, Cerebrospinal Fluid (CSF) Management Devices and Other. Based on Service and Treatment, the market is segmented into Electroencephalogram, Intrathecal Baclofen Therapy, Neurological Evaluations and Vagal Nerve Stimulation. Based on Neurological Specialty, the market is segmented into Neuro-Oncology, Neuromuscular, Neonatal Neurology, Neuro-Immunology and Stroke. Based on Age Group, the market is segmented into Neonates, Infants, Children and Adolescents. Based on End User, the market is segmented into Hospital, Healthcare Center, Specialty Clinics and Neurological Research Centres. Based on Application, the market is segmented into Brain Tumour, Epilepsy, Autism Spectrum Disorder, Parkinson's Disease and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pediatric Neurology Device Market

The Pediatric Neurology Device market is being significantly influenced by the growing awareness of neurological diseases across all age demographics. This surge in awareness is largely attributed to the rising prevalence of neurological disorders and various global initiatives aimed at educating the public. Furthermore, the increasing mortality rates associated with these conditions are contributing to the heightened demand for pediatric neurology devices. As more individuals and families recognize the impact of neurological ailments, there is a corresponding growth in the need for effective diagnostic and therapeutic tools tailored for children, fostering market expansion and innovation within the pediatric neurology sector.

Restraints in the Pediatric Neurology Device Market

The Pediatric Neurology Device market is significantly constrained by the high costs associated with treating neurological disorders. These treatments often involve advanced and costly neurological devices, which can lead to substantial financial burdens for families. Additionally, pediatric neurology devices are specifically engineered for children's unique needs, further limiting their applicability and driving up expenses. As a result, the steep prices of these specialized devices contribute to the overall treatment costs, making it challenging for patients and their families to afford necessary care. This economic barrier poses a significant obstacle to market growth and accessibility in the pediatric field.

Market Trends of the Pediatric Neurology Device Market

The Pediatric Neurology Device market is experiencing a significant trend toward better diagnosis of neurological diseases, driven by advancements in healthcare technology. Manufacturers are leveraging cutting-edge technologies, including artificial intelligence, advanced medical imaging, and machine learning, to enhance the diagnostic accuracy of their devices. This evolution presents a substantial growth opportunity for suppliers as healthcare providers increasingly seek innovative solutions for the complex challenges in diagnosing pediatric neurological disorders. As a result, the market is poised for expansion, with investments in research and development likely to propel the introduction of more sophisticated and effective diagnostic tools in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Pediatric Neurology Device Market Size by Product & CAGR (2025-2032)

• Market Overview
• Neurosurgery Devices
• Neurostimulator
• Cerebrospinal Fluid (CSF) Management Devices
• Other

Global Pediatric Neurology Device Market Size by Service and Treatment & CAGR (2025-2032)

• Market Overview
• Electroencephalogram
• Intrathecal Baclofen Therapy
• Neurological Evaluations
• Vagal Nerve Stimulation

Global Pediatric Neurology Device Market Size by Neurological Specialty & CAGR (2025-2032)

• Market Overview
• Neuro-Oncology
• Neuromuscular
• Neonatal Neurology
• Neuro-Immunology
• Stroke

Global Pediatric Neurology Device Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Neonates
• Infants
• Children
• Adolescents

Global Pediatric Neurology Device Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital
• Healthcare Center
• Specialty Clinics
• Neurological Research Centres

Global Pediatric Neurology Device Market Size by Application & CAGR (2025-2032)

• Market Overview
• Brain Tumour
• Epilepsy
• Autism Spectrum Disorder
• Parkinson's Disease
• Others

Global Pediatric Neurology Device Market Size & CAGR (2025-2032)

• North America (Product, Service and Treatment, Neurological Specialty, Age Group, End User, Application)
  • US
  • Canada
• Europe (Product, Service and Treatment, Neurological Specialty, Age Group, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Service and Treatment, Neurological Specialty, Age Group, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Service and Treatment, Neurological Specialty, Age Group, End User, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Service and Treatment, Neurological Specialty, Age Group, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Computational Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith+Nephew (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mizuho OSI (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orpyx Medical Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Magstim (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations